Skip to content

Drug interactions

Lenacapavir + Rivaroxaban

Severity: Moderate

Lenacapavir and Rivaroxaban: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lenacapavir is a moderate CYP3A inhibitor and may also inhibit P-glycoprotein, which could raise rivaroxaban exposure and bleeding risk, particularly with renal impairment.

What this interaction means in plain words

Lenacapavir and Rivaroxaban can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Lenacapavir belongs to Anti Virals; Rivaroxaban belongs to Cardiovascular.

Evidence level: Low

Why it happens

Inhibition of CYP3A4 and P-glycoprotein reduces rivaroxaban clearance.

What to do

Monitor for bleeding and check renal function. Consider an alternative anticoagulant in patients with significant renal impairment.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lenacapavir and Rivaroxaban, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Lenacapavir with Rivaroxaban?

MediHelp rates the interaction as moderate. Lenacapavir and Rivaroxaban can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Lenacapavir is a moderate CYP3A inhibitor and may also inhibit P-glycoprotein, which could raise rivaroxaban exposure and bleeding risk, particularly with renal impairment.

How serious is the interaction between Lenacapavir and Rivaroxaban?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for bleeding and check renal function. Consider an alternative anticoagulant in patients with significant renal impairment.

What other medicines interact with Rivaroxaban?

MediHelp also lists interactions of Rivaroxaban with, for example, Defibrotide, Ketoconazole, Ketorolac. The full list is on the Rivaroxaban page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in